Ambit Partners with Datavant to Drive Innovation in ​​the Rare and Specialty Disease Markets​​
MORRISTOWN, NJ, September 19, 2023 – Ambit, a leading integrated biopharma solutions firm specializing in the rare and specialty disease markets, is pleased to announce a partnership with Datavant, the leader in helping organizations securely connect health data, to accelerate data-driven innovation for biopharma companies. Ambit’s mission is to achieve ultimate client…